Skip to content

Construction and Validation of Integrated Disease-Syndrome Subtypes of Polycystic Ovary Syndrome Based on Real-World Data

Construction and Validation of Integrated Disease-Syndrome Subtypes of Polycystic Ovary Syndrome Based on Real-World Data

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000387
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-03-15
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome (PCOS)

Interventions

Polycystic Ovary Syndrome:unlimited

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
14 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1)Meets the diagnostic criteria for PCOS: meets the diagnostic criteria for PCOS: referring to the diagnostic criteria for adult and adolescent PCOS specified in the 2023 International Evidence-Based Guidelines for the Assessment and Management of Polycystic Ovary Syndrome; 2) Aged between 14 and 40 years old; 3) Voluntarily signs the informed consent form and is willing to cooperate with follow-up visits.

Exclusion criteria

Exclusion criteria: 1) Congenital adrenal hyperplasia, Cushing's syndrome, androgen-secreting tumors, and other causes of non-PCOS-related hyperandrogenism; 2) Hyperprolactinemia, premature ovarian failure, thyroid dysfunction, and other endocrine disorders causing menstrual irregularities; 3) Complicated with severe cardiovascular and cerebrovascular diseases, hepatic or renal insufficiency, or malignant tumors; 4) Pregnant or lactating women; 5) Subjects who have participated in other drug clinical trials within the past month.

Design outcomes

Primary

MeasureTime frame
Information on the Four Diagnostic Methods in Traditional Chinese Medicine;

Secondary

MeasureTime frame
Sex hormone indicators: Follicle-stimulating hormone, luteinizing hormone, estradiol , sex hormone-binding globulin , dehydroepiandrosterone sulfate, testosterone prolactin, progesterone, etc;Biochemical indicators: Oral glucose tolerance test , insulin release test, glycated hemoglobin, insulin resistance index ; Six lipid items, etc;

Countries

China

Contacts

Public ContactXuefang Liang

Guangdong Provincial Hospital of Chinese Medicine

liangxuefang@gzucm.edu.cn13926082916

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026